XML 26 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2012
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table presents revenues, gross profit and operating income by reportable segment (in thousands):

 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2012
 
2011
 
2012
 
2011
Revenues:
 
 
 
 
 
 
 
Apex
$
99,004

 
$

 
$
99,004

 
$

Oxford
88,107

 
65,319

 
166,866

 
125,438

Life Sciences
40,509

 
39,626

 
81,860

 
72,583

Healthcare
30,527

 
21,736

 
53,406

 
41,580

Physician
25,039

 
17,002

 
49,128

 
33,520

Total Revenues
$
283,186

 
$
143,683

 
$
450,264

 
$
273,121

Gross Profit:
 
 
 
 
 
 
 
Apex
$
26,983

 
$

 
$
26,983

 
$

Oxford
31,646

 
23,412

 
59,016

 
44,370

Life Sciences
13,808

 
13,592

 
27,647

 
24,862

Healthcare
8,799

 
6,157

 
15,139

 
11,784

Physician
7,718

 
5,633

 
15,217

 
10,932

Total Gross Profit
$
88,954

 
$
48,794

 
$
144,002

 
$
91,948

Operating Income (Loss):
 
 
 
 
 
 
 
Apex (1)
$
(1,969
)
 
$

 
$
(1,969
)
 
$

Oxford
15,521

 
8,002

 
22,756

 
13,976

Life Sciences
2,963

 
2,891

 
5,271

 
4,352

Healthcare
1,155

 
(1,234
)
 
481

 
(2,901
)
Physician
1,984

 
1,136

 
3,062

 
1,767

Total Operating Income
$
19,654

 
$
10,795

 
$
29,601

 
$
17,194

 (1) Apex operating income includes acquisition related costs.

Schedule of Revenue by Geographical Areas
The Company operates internationally, with operations mainly in the United States, Europe, Canada, Australia and New Zealand. The following table presents revenues by geographic location (in thousands):

 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2012
 
2011
 
2012
 
2011
Revenues:
 
 
 
 
 
 
 
Domestic
$
264,198

 
$
124,005

 
$
411,960

 
$
240,290

Foreign
18,988

 
19,678

 
38,304

 
32,831

Total Revenues
$
283,186

 
$
143,683

 
$
450,264

 
$
273,121

Reconciliation of Assets from Segment to Consolidated
The Company does not report Life Sciences and Healthcare segments’ total assets separately as the operations are largely centralized. The following table presents total assets as allocated by reportable segment (in thousands):

 
June 30, 2012
 
December 31, 2011
Total Assets:

 

Apex
$
658,380

 
$

Oxford
225,355

 
218,810

Life Sciences and Healthcare
127,145

 
107,915

Physician
83,868

 
83,940

Total Assets
$
1,094,748

 
$
410,665